| Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review L Farah, J Davaze-Schneider, T Martin, P Nguyen, I Borget, N Martelli Artificial Intelligence in Medicine, 102547, 2023 | 17 | 2023 |
| Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France T Martin, A Guercio, H Besseau, L Huot, P Guerre, J Atfeh, L Piazza, ... International Journal of Technology Assessment in Health Care 39 (1), e58, 2023 | 1 | 2023 |
| Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus I Lipska, R Di Bidino, M Niewada, B Nemeth, T Bochenek, M Kukla, ... Healthcare 12 (9), 889, 2024 | | 2024 |
| Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs T Martin, C Rioufol, B Favier, N Martelli, I Madelaine, C Chouaid, I Borget BioDrugs, 1-11, 2024 | | 2024 |
| P32 Implementation of Early Access Reform in France and Access to Innovation: Impact in Terms of Number of Drugs, Patients Treated, and Cost T Martin, C Rioufol, N Martelli, I Madelaine, I Borget Value in Health 26 (12), S8, 2023 | | 2023 |
| Economic and organisational impacts of medical device regulation in Europe: Is the price too high for small and medium enterprises? M Saia, P Cavagna, T Martin, V Beretta, J Pineau, N Martelli Health Policy and Technology 12 (4), 100789, 2023 | | 2023 |
| HPR41 Linking the Price of a Drug to Its Real-Life Performance: A Solution for Financing Innovative Therapies in France? S Azzazene, T Martin, I Borget Value in Health 26 (12), S261, 2023 | | 2023 |
